Mini-Oral Abstract Presentations I
Chaired by: Léhila Bagnan Tossa and Tiwadayo Braimoh
12:25 PM – Successful Integration of Recent HIV Infection Surveillance in Routine HIV Testing Services to Identify Risk Factors Among Newly Diagnosed HIV Individuals Aged 15 Years and Above in North-Eastern Uganda, 2020-2023
#9 – Saadick Ssentongo, Uganda
12:28 PM – Pharmacokinetic Interaction Assessment of the HIV Broadly Neutralizing Monoclonal Antibody VRC07-523LS: A Cross-Protocol Analysis of Three Phase 1 HIV Prevention Trials HVTN127/HPTN087, HVTN130/HPTN089 and HVTN136/HPTN092
#10 – Tariro Dianah Mutingwende, Zimbabwe
12:31 PM – Harnessing Technology and counsellors’ insights to promote HIV prevention: The ‘Undetectable & You (U)’ App in disseminating U = U information in South Africa
#11 – Sharon Kgowedi, South Africa
12:34 PM – Acceptability of Pharmacy-Based Pre-Exposure Prophylaxis (PrEP) Refills for People Who Sell Sex in Zimbabwe
#12 – Sharon Munhenzva, Zimbabwe
12:37 PM – Exploring Pregnant Women’s Experiences with Vaginal Ring Insertion during the Mtn-042/ Deliver Study at Mujhu Care Limited Kampala, Uganda
#13 – Joselyne Nansimbe, Uganda
12:40 PM – Integrating PrEP Delivery in Public Family Planning Clinics Increases PrEP Screening and Uptake: Results from a Large Stepped-wedge, Cluster-randomized Trial in Kenya
#14 – Daniel Matemo, Kenya
12:43 PM – Audience Q&A
